US 6417338
Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
expired A61KA61K38/00
Quick answer
US patent 6417338 (Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00